OceansBio develops an AI-based vagus nerve stimulation (VNS) platform - electroceutical technology that analyzes a patient's biosignals (ECG, HRV) to predict physiological events and guide precise electrical stimulation. This core AI-VNS platform powers three products spanning wellness, medical devices, and software as a medical device: BeCozU, a consumer wellness wearable for sleep and stress; Statera, a transcutaneous auricular VNS (taVNS) medical device targeting insomnia and depression; and Praevisa, an AI-based seizure-prediction software platform (SaMD) for implantable VNS devices targeting epilepsy.